| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,582 |
25,810 |
$3.37M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,485 |
12,503 |
$2.57M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,594 |
6,156 |
$2.38M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,363 |
11,114 |
$1.16M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,160 |
15,137 |
$1.10M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,969 |
4,780 |
$677K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,183 |
1,172 |
$597K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,124 |
1,117 |
$514K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
24,443 |
6,858 |
$486K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,151 |
2,121 |
$435K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,212 |
1,208 |
$412K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,604 |
3,733 |
$411K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,567 |
2,992 |
$349K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,128 |
1,285 |
$325K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,581 |
3,456 |
$317K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,991 |
8,862 |
$256K |
| 80061 |
Lipid panel |
8,998 |
8,926 |
$248K |
| 71046 |
Radiologic examination, chest; 2 views |
7,092 |
6,775 |
$238K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,965 |
9,572 |
$236K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
104 |
104 |
$234K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
948 |
942 |
$199K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,648 |
2,603 |
$198K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,881 |
3,969 |
$195K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,509 |
1,491 |
$187K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
8,340 |
3,453 |
$182K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,634 |
1,549 |
$172K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,495 |
1,451 |
$161K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
448 |
437 |
$157K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,093 |
3,090 |
$147K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,768 |
3,366 |
$134K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,772 |
5,525 |
$130K |
| 71045 |
Radiologic examination, chest; single view |
3,634 |
3,392 |
$125K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
242 |
238 |
$123K |
| G0378 |
Hospital observation service, per hour |
3,511 |
1,801 |
$121K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
230 |
230 |
$95K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
186 |
186 |
$89K |
| 97161 |
|
1,668 |
1,636 |
$81K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,564 |
2,394 |
$80K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,421 |
1,391 |
$75K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
674 |
666 |
$65K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
796 |
772 |
$61K |
| 94060 |
|
490 |
485 |
$60K |
| S4005 |
Interim labor facility global (labor occurring but not resulting in delivery) |
464 |
337 |
$50K |
| 80053 |
Comprehensive metabolic panel |
40,942 |
35,642 |
$44K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
336 |
335 |
$42K |
| 93975 |
|
353 |
335 |
$38K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
48 |
48 |
$38K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,519 |
13,098 |
$38K |
| 97162 |
|
771 |
742 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,215 |
37,990 |
$35K |
| 97014 |
|
4,137 |
1,361 |
$32K |
| 94726 |
|
1,209 |
1,187 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,130 |
5,089 |
$30K |
| 76830 |
Ultrasound, transvaginal |
543 |
522 |
$30K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,640 |
2,598 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,594 |
2,554 |
$28K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,188 |
10,666 |
$28K |
| 76536 |
|
516 |
512 |
$26K |
| 96367 |
|
575 |
403 |
$25K |
| 95800 |
|
300 |
297 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,020 |
380 |
$23K |
| 82947 |
|
1,124 |
813 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,037 |
6,174 |
$21K |
| 93017 |
|
948 |
935 |
$20K |
| 72110 |
|
530 |
521 |
$18K |
| 92526 |
|
429 |
169 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,294 |
4,885 |
$17K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,339 |
1,298 |
$17K |
| 76642 |
|
421 |
411 |
$16K |
| 97035 |
|
2,875 |
1,204 |
$16K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
497 |
359 |
$16K |
| 73630 |
|
1,788 |
1,730 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
47,757 |
39,542 |
$14K |
| 71271 |
|
244 |
244 |
$14K |
| 73564 |
|
1,062 |
1,037 |
$14K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,706 |
1,683 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,118 |
1,118 |
$14K |
| 87390 |
|
1,817 |
1,806 |
$14K |
| 73030 |
|
1,271 |
1,221 |
$13K |
| 97533 |
|
376 |
142 |
$13K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
229 |
224 |
$13K |
| 72141 |
|
109 |
109 |
$13K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,656 |
1,652 |
$12K |
| 73610 |
|
1,638 |
1,565 |
$12K |
| 82607 |
|
3,848 |
3,794 |
$12K |
| 82728 |
|
3,752 |
3,626 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
798 |
776 |
$11K |
| 97535 |
Self-care/home management training, each 15 minutes |
744 |
473 |
$11K |
| 97116 |
|
969 |
337 |
$10K |
| 86900 |
|
1,487 |
1,416 |
$10K |
| 80055 |
|
538 |
535 |
$10K |
| 74018 |
|
728 |
669 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,781 |
6,698 |
$9K |
| 73130 |
|
1,389 |
1,332 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
767 |
744 |
$9K |
| 86702 |
|
1,817 |
1,806 |
$8K |
| 96415 |
|
201 |
153 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,864 |
6,502 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
830 |
781 |
$7K |
| 82746 |
|
2,145 |
2,113 |
$7K |
| 83880 |
|
2,299 |
2,099 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,565 |
4,283 |
$7K |
| 86803 |
|
1,525 |
1,518 |
$6K |
| 83735 |
|
10,471 |
8,390 |
$6K |
| 93971 |
|
120 |
117 |
$6K |
| 88304 |
|
1,508 |
1,484 |
$6K |
| 77336 |
|
89 |
38 |
$6K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
385 |
383 |
$6K |
| 87081 |
|
4,374 |
4,295 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,210 |
3,631 |
$5K |
| 84439 |
|
3,143 |
3,089 |
$5K |
| 73110 |
|
871 |
827 |
$5K |
| 86701 |
|
1,827 |
1,816 |
$5K |
| 87653 |
|
375 |
371 |
$5K |
| 87522 |
Neg quan hep c or qual rna |
325 |
318 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,738 |
8,318 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
85 |
85 |
$5K |
| 87660 |
|
1,061 |
1,035 |
$5K |
| 87480 |
|
1,061 |
1,035 |
$5K |
| 70486 |
|
119 |
118 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
128 |
120 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,591 |
6,871 |
$5K |
| 83540 |
|
3,114 |
2,996 |
$4K |
| 87510 |
|
1,044 |
1,020 |
$4K |
| 74019 |
|
252 |
239 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
39 |
39 |
$4K |
| 85027 |
|
6,080 |
5,462 |
$4K |
| 83550 |
|
1,970 |
1,886 |
$4K |
| 71250 |
|
62 |
62 |
$3K |
| 84702 |
|
1,381 |
1,078 |
$3K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
12 |
12 |
$3K |
| 72100 |
|
102 |
97 |
$3K |
| 59025 |
Fetal non-stress test |
30 |
26 |
$3K |
| 73221 |
|
28 |
27 |
$3K |
| 73502 |
|
260 |
249 |
$3K |
| 87077 |
|
2,278 |
2,124 |
$3K |
| 88342 |
|
329 |
323 |
$3K |
| 87186 |
|
2,130 |
2,000 |
$3K |
| 85610 |
|
5,445 |
4,578 |
$2K |
| 86140 |
|
3,850 |
3,453 |
$2K |
| 87070 |
|
1,616 |
1,531 |
$2K |
| 84484 |
|
9,680 |
5,646 |
$2K |
| 97165 |
|
57 |
51 |
$2K |
| 86850 |
|
1,609 |
1,538 |
$2K |
| 70491 |
|
14 |
14 |
$2K |
| 86038 |
|
738 |
734 |
$2K |
| 87902 |
|
30 |
30 |
$2K |
| 80076 |
|
857 |
821 |
$1K |
| 73140 |
|
217 |
204 |
$1K |
| 82570 |
|
1,642 |
1,546 |
$1K |
| 81001 |
|
10,089 |
9,437 |
$1K |
| 87340 |
|
383 |
382 |
$1K |
| 83516 |
|
373 |
182 |
$1K |
| 84100 |
|
1,161 |
813 |
$1K |
| 86706 |
|
339 |
337 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,159 |
2,111 |
$1K |
| 29125 |
|
208 |
183 |
$1K |
| 82950 |
|
682 |
680 |
$1K |
| 93296 |
|
57 |
57 |
$1K |
| 86780 |
|
233 |
231 |
$990.19 |
| 85652 |
|
2,510 |
2,414 |
$967.36 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
596 |
577 |
$889.44 |
| 83690 |
|
6,082 |
5,497 |
$866.20 |
| 83615 |
|
856 |
752 |
$846.21 |
| 87205 |
|
1,465 |
1,380 |
$832.75 |
| 85730 |
|
2,604 |
2,225 |
$755.56 |
| 86777 |
|
131 |
131 |
$721.76 |
| 72050 |
|
13 |
13 |
$715.55 |
| 84550 |
|
637 |
531 |
$696.23 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
296 |
296 |
$679.92 |
| 82043 |
|
1,204 |
1,199 |
$679.09 |
| 84481 |
|
230 |
226 |
$671.52 |
| 93225 |
|
12 |
12 |
$647.90 |
| 82150 |
|
1,961 |
1,830 |
$637.44 |
| 81003 |
|
8,052 |
7,718 |
$605.59 |
| 73080 |
|
126 |
122 |
$557.13 |
| 84153 |
|
131 |
129 |
$531.54 |
| 82565 |
|
2,462 |
2,287 |
$492.97 |
| 73700 |
|
12 |
12 |
$455.35 |
| 77065 |
Tomosynthesis, mammo |
13 |
13 |
$449.60 |
| 90686 |
|
38 |
33 |
$418.66 |
| 82948 |
|
4,769 |
2,624 |
$403.79 |
| 73562 |
|
31 |
28 |
$398.94 |
| 94010 |
|
118 |
111 |
$392.91 |
| 86787 |
|
81 |
81 |
$373.08 |
| 70496 |
|
13 |
13 |
$365.14 |
| 81025 |
|
9,300 |
8,621 |
$356.07 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,404 |
2,240 |
$349.60 |
| 83970 |
|
40 |
40 |
$306.29 |
| 86431 |
|
265 |
264 |
$292.60 |
| 87040 |
|
1,998 |
1,157 |
$289.95 |
| 87075 |
|
274 |
254 |
$286.01 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
25 |
25 |
$273.17 |
| 83001 |
|
64 |
63 |
$241.24 |
| 73090 |
|
12 |
12 |
$240.70 |
| 74022 |
|
29 |
29 |
$231.82 |
| 85379 |
|
2,023 |
1,948 |
$213.15 |
| 70498 |
|
14 |
14 |
$212.48 |
| 86901 |
|
1,782 |
1,697 |
$204.14 |
| 86704 |
|
51 |
51 |
$203.54 |
| 83874 |
|
2,815 |
1,631 |
$175.60 |
| G0008 |
Administration of influenza virus vaccine |
45 |
39 |
$168.00 |
| 82550 |
|
302 |
265 |
$163.23 |
| 82977 |
|
88 |
87 |
$138.74 |
| 84403 |
|
62 |
61 |
$129.63 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,762 |
10,442 |
$124.08 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,228 |
6,737 |
$115.00 |
| 88142 |
|
15 |
15 |
$113.88 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
71 |
69 |
$105.19 |
| 86738 |
|
512 |
497 |
$104.63 |
| 82553 |
|
2,833 |
1,642 |
$100.72 |
| 87430 |
|
1,707 |
1,681 |
$90.70 |
| 83605 |
|
4,423 |
3,783 |
$86.56 |
| 84450 |
|
68 |
66 |
$82.17 |
| 82784 |
|
27 |
27 |
$80.64 |
| 82670 |
|
16 |
16 |
$79.25 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,154 |
10,323 |
$69.72 |
| 84156 |
|
103 |
88 |
$68.77 |
| 82172 |
|
14 |
14 |
$66.25 |
| 84460 |
|
51 |
49 |
$63.15 |
| 71101 |
|
12 |
12 |
$60.49 |
| 12001 |
|
374 |
367 |
$58.33 |
| 82077 |
|
841 |
736 |
$47.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,427 |
2,845 |
$46.24 |
| 83010 |
|
14 |
14 |
$43.84 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
988 |
978 |
$38.77 |
| 84425 |
|
14 |
14 |
$32.48 |
| 80143 |
|
474 |
429 |
$30.80 |
| 80179 |
|
469 |
426 |
$30.80 |
| 84132 |
|
101 |
74 |
$28.23 |
| 83721 |
|
13 |
13 |
$26.87 |
| 86769 |
|
12 |
12 |
$24.65 |
| 80178 |
|
17 |
14 |
$24.12 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,340 |
1,267 |
$23.00 |
| J2704 |
Injection, propofol, 10 mg |
7,370 |
7,168 |
$23.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,607 |
5,763 |
$23.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,141 |
6,657 |
$23.00 |
| 82248 |
|
18 |
14 |
$20.32 |
| J2060 |
Injection, lorazepam, 2 mg |
1,990 |
1,673 |
$19.00 |
| 84145 |
|
124 |
122 |
$17.93 |
| 82247 |
|
19 |
16 |
$17.50 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
337 |
319 |
$10.00 |
| 86308 |
|
56 |
55 |
$9.32 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
266 |
222 |
$9.24 |
| 85018 |
|
14 |
12 |
$6.87 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,006 |
2,461 |
$2.58 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
489 |
421 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
629 |
540 |
$0.00 |
| 94664 |
|
1,415 |
1,161 |
$0.00 |
| 88313 |
|
321 |
283 |
$0.00 |
| 84520 |
|
16 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,908 |
1,510 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,696 |
2,230 |
$0.00 |
| 90715 |
|
505 |
498 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
310 |
228 |
$0.00 |
| 94729 |
|
1,226 |
1,204 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,111 |
1,011 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
262 |
190 |
$0.00 |
| 99152 |
|
399 |
375 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,110 |
1,037 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
49 |
49 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
128 |
113 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
96 |
87 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
216 |
201 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
236 |
189 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
80 |
66 |
$0.00 |
| 88312 |
|
28 |
28 |
$0.00 |
| 93325 |
|
68 |
68 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
27 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
64 |
39 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
16 |
16 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
17 |
14 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
28 |
28 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
14 |
14 |
$0.00 |
| 73590 |
|
13 |
13 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,547 |
1,285 |
$0.00 |
| 96376 |
|
2,717 |
1,850 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,133 |
1,080 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
282 |
249 |
$0.00 |
| 97010 |
|
4,480 |
1,450 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
529 |
517 |
$0.00 |
| C1769 |
Guide wire |
86 |
81 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
135 |
47 |
$0.00 |
| 72170 |
|
13 |
13 |
$0.00 |
| 12002 |
|
12 |
12 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
339 |
143 |
$0.00 |
| J3490 |
Unclassified drugs |
3,602 |
2,086 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
42 |
40 |
$0.00 |
| A9270 |
Non-covered item or service |
9,678 |
4,861 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
326 |
270 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
497 |
481 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
637 |
457 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
269 |
247 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
126 |
126 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
209 |
206 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
112 |
109 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
14 |
12 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
90 |
69 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
79 |
78 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
45 |
45 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
19 |
13 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$0.00 |
| 77417 |
|
28 |
12 |
$0.00 |
| 93320 |
|
12 |
12 |
$0.00 |